111 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
and drug developers, complemented by an experienced Board and world-class scientific advisors. This group shares a long-term commitment to execute our … designation in addition to intensive guidance on an efficient development program beginning as early as Phase 1, and FDA organizational commitment
8-K
EX-10.1
5wsm iad02rs
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K/A
EX-99.3
plih5gk g9a8itp
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
425
EX-99.2
4anfaee55kb5l2893p89
9 Aug 23
Business combination disclosure
4:02pm
8-K
EX-99.2
7104 oxq2kfw9ppd
9 Aug 23
Other Events
4:02pm
424B3
91o2 w9agcu
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
jh4vcyabkd29vhd9o
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
qj53 xbk1ftteuye
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.30
zjxc42l6mzd 0c4mbx5m
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
hw42hr0aasjaw6eb
30 Mar 23
Business combination disclosure
8:51am
425
EX-99.2
a8e63hkqmy8shhg6
30 Mar 23
Business combination disclosure
8:51am
425
EX-10.2
5woz9 np8dt059
30 Mar 23
Business combination disclosure
8:51am